Leavell Investment Management »

Crispr Therapeutics shares owned by Leavell Investment Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Leavell Investment Management from 13F filings

Historical chart of Leavell Investment Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Leavell Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Leavell Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $716k 11k 68.19
2023-12-31 $657k 11k 62.57
2023-09-30 $277k 6.1k 45.41

More positions owned by Leavell Investment Management

NVIDIA Corporation (NVDA)
Vanguard Mega Cap ETF Mega Cap Index (MGC)
Apple (AAPL)
Vanguard Mid Cap ETF Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Mega Growth ETF Mega Grwth Ind (MGK)
Vanguard Large-Cap Index Fund ETF Shares Large Cap Etf (VV)
Blackstone Group Com Cl A (BX)
Vanguard FTSE Developed ETF Ftse Dev Mkt Etf (VEA)
Vanguard Small Cap ETF Small Cp Etf (VB)
Schwab Fundamental Inl Large Com ETF Schwb Fdt Int Lg (FNDF)
Vanguard S&P 500 ETF S&p 500 Etf Shs (VOO)
SCHW Intl Eq ETF Intl Eqty Etf (SCHF)
Schwab Short U.S. Treasury ETF Sht Tm Us Tres (SCHO)
JPMorgan Chase & Co. (JPM)

View all positions for Leavell Investment Management

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Morgan Stanley
Bank of America Corporation
Loomis, Sayles and
Dimensional Fund Advisors

View all funds holding Crispr Therapeutics